Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Orange County Research Center, Lake Forest, California Orlando Clinical Research Center, Orlando, Florida Genesis Clinical Research, LLC, Tampa, Florida Nucleus Network, Saint Paul, Minnesota